We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Three companies have merged to form the UK’s first nationwide life sciences ecosystem, boosting R&D and drug discovery capacity in the country and giving early-stage companies access to much-needed investment and facilities.
BioCity with its 29 earlier investments in life science ventures, specialises in seed funding via convertible loans for very early-stage ventures and co-investment in growing life science ventures.